BR0114400A - Uso de bactéria de ácido lático probiótica para equilibrar o sistema imunológico da pele - Google Patents

Uso de bactéria de ácido lático probiótica para equilibrar o sistema imunológico da pele

Info

Publication number
BR0114400A
BR0114400A BR0114400-6A BR0114400A BR0114400A BR 0114400 A BR0114400 A BR 0114400A BR 0114400 A BR0114400 A BR 0114400A BR 0114400 A BR0114400 A BR 0114400A
Authority
BR
Brazil
Prior art keywords
skin
balance
lactic acid
acid bacteria
immune system
Prior art date
Application number
BR0114400-6A
Other languages
English (en)
Other versions
BRPI0114400B8 (pt
BR0114400B1 (pt
Inventor
Markus Baur
Lionel Breton
Francois Couzy
Audrey Gueniche
Original Assignee
Nestle Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestle Sa filed Critical Nestle Sa
Publication of BR0114400A publication Critical patent/BR0114400A/pt
Publication of BR0114400B1 publication Critical patent/BR0114400B1/pt
Publication of BRPI0114400B8 publication Critical patent/BRPI0114400B8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/99—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biotechnology (AREA)
  • Birds (AREA)
  • Molecular Biology (AREA)
  • Pulmonology (AREA)
  • Toxicology (AREA)
  • Pain & Pain Management (AREA)
  • Nutrition Science (AREA)
  • Rheumatology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Feed For Specific Animals (AREA)
  • Fodder In General (AREA)

Abstract

"USO DE BACTéRIA DE áCIDO LáTICO PROBIóTICA PARA EQUILIBRAR O SISTEMA IMUNOLóGICO DA PELE". A presente invenção refere-se ao uso de probióticos para a preparação de um veículo para equilibrar a função imunológica da pele. Em particular, a presente invenção pertence ao uso de microorganismos probióticos para equilibrar a função imunológica da pele sobcondições de tensão, tal como uma exposição a radiação ultravioleta, especificamente para acentuar a atividade imunológica da pele e reduzir a tendência a desenvolver reações alérgicas sob tais condições.
BRPI0114400A 2000-10-06 2001-10-04 uso de bactéria de ácido lático probiótica para equilibrar o sistema imunológico da pele BRPI0114400B8 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP00121865 2000-10-06
EP00121865.0 2000-10-06
PCT/EP2001/011475 WO2002028402A1 (en) 2000-10-06 2001-10-04 Use of probiotic lactic acid bacteria for balancing the skin's immune system

Publications (3)

Publication Number Publication Date
BR0114400A true BR0114400A (pt) 2003-08-26
BR0114400B1 BR0114400B1 (pt) 2014-04-01
BRPI0114400B8 BRPI0114400B8 (pt) 2021-05-25

Family

ID=8170032

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0114400A BRPI0114400B8 (pt) 2000-10-06 2001-10-04 uso de bactéria de ácido lático probiótica para equilibrar o sistema imunológico da pele

Country Status (14)

Country Link
US (2) US7547527B2 (pt)
EP (2) EP1593382A1 (pt)
JP (1) JP4510376B2 (pt)
CN (1) CN100553646C (pt)
AR (1) AR033580A1 (pt)
AT (1) ATE490776T1 (pt)
AU (2) AU2058702A (pt)
BR (1) BRPI0114400B8 (pt)
CA (1) CA2424607C (pt)
DE (1) DE60143616D1 (pt)
ES (1) ES2357419T3 (pt)
MX (1) MXPA03002957A (pt)
PT (1) PT1322318E (pt)
WO (1) WO2002028402A1 (pt)

Families Citing this family (80)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL372146A1 (en) * 2002-02-21 2005-07-11 Societe Des Produits Nestle S.A. Orally administrable composition for the photoprotection of the skin
FR2844198A1 (fr) * 2002-09-06 2004-03-12 Oreal Utilisation d'un activeur de protectin pour ameliorer la resistance de la peau, composition contenant de tels activateurs et procede de selection
WO2004069156A2 (en) * 2003-01-30 2004-08-19 The Regents Of The University Of California Inactivated probiotic bacteria and methods of use thereof
ATE421256T1 (de) * 2003-03-13 2009-02-15 Kirin Holdings Kk Probiotische zusammensetzung
US20050158294A1 (en) 2003-12-19 2005-07-21 The Procter & Gamble Company Canine probiotic Bifidobacteria pseudolongum
US8877178B2 (en) 2003-12-19 2014-11-04 The Iams Company Methods of use of probiotic bifidobacteria for companion animals
KR20070070153A (ko) 2004-06-23 2007-07-03 로레알 민감성 및/또는 건성 피부의 예방 및/또는 치료에 유용한방법 및 조성물
AU2005291098B2 (en) * 2004-10-04 2011-11-24 L'oreal Cosmetic and/or dermatological composition for sensitive skins
EP1683425A1 (en) 2005-01-21 2006-07-26 Compagnie Gervais Danone Use of a fermented milk containing L. Casei for the manufacture of a composition for the prevention or treatment of a delayed-type hypersensitivity reaction
US20060251634A1 (en) * 2005-05-06 2006-11-09 Ho-Jin Kang Method of improving immune function in mammals using lactobacillus strains with certain lipids
WO2006130188A1 (en) 2005-05-31 2006-12-07 The Iams Company Feline probiotic bifidobacteria
DK1880001T3 (da) 2005-05-31 2011-09-12 Iams Company Feline probiotiske lactobacilli
EP1736537A1 (en) * 2005-06-22 2006-12-27 OrganoBalance GmbH Methods and means for protecting the skin against pathogenic microorganisms
JP5160889B2 (ja) * 2005-06-24 2013-03-13 カルピス株式会社 表皮細胞分化及び角化促進剤
FR2889057B1 (fr) * 2005-08-01 2008-07-18 Oreal Composition cosmetique et/ou dermatologique pour la prevention et/ou le traitement des peaux sensibles ou seches
EP1946651B1 (en) 2005-10-18 2011-03-23 Kao Corporation Pet foods
CN101588809B (zh) * 2006-12-26 2013-04-24 株式会社明治 皮肤改善用和/或治疗用发酵奶和其制造方法
JP5799299B2 (ja) 2007-02-01 2015-10-21 ザ・アイムス・カンパニーＴｈｅ Ｉａｍｓ Ｃｏｍｐａｎｙ ブドウ糖代謝拮抗物質、アボカド又はアボカド抽出物を使用する、哺乳動物における炎症及びストレスの低下方法
FR2912917B1 (fr) * 2007-02-26 2012-05-18 Oreal Milieu conditionne et ses utilisations
FR2912916B1 (fr) * 2007-02-26 2009-05-22 Oreal Composition cosmetique ou dermatologique comprenant un milieu de culture cellulaire
KR20100016101A (ko) * 2007-03-30 2010-02-12 산토리 홀딩스 가부시키가이샤 부교감 신경 활동 항진 작용을 갖는 의약 조성물 또는 음식물
JP2009102292A (ja) * 2007-04-27 2009-05-14 Chiba Prefecture ストレス抑制剤
FR2919501B1 (fr) * 2007-08-02 2010-12-31 Oreal Utilisation d'hesperidine ou de l'un de ses derives pour la prevention et/ou le traitement des peaux relachees
FR2920304B1 (fr) 2007-09-04 2010-06-25 Oreal Utilisation cosmetique de lysat bifidobacterium species pour le traitement de la secheresse.
FR2920307B1 (fr) * 2007-09-04 2010-06-04 Oreal Utilisation cosmetique de microorganismes.
FR2920305B1 (fr) 2007-09-04 2010-07-30 Oreal Utilisation d'un lysat de bifidobacterium species pour le traitement de peaux sensibles.
EP2082731B1 (fr) * 2007-09-04 2014-02-19 L'Oréal Utilisation d'une association d'hespéridine et d'un microorganisme pour agir sur la fonction barrière de la peau
FR2920300B1 (fr) * 2007-09-04 2012-12-28 Oreal Utilisation d'une association hesperidine et microorganisme pour agir sur la fonction barriere de la peau.
US9771199B2 (en) 2008-07-07 2017-09-26 Mars, Incorporated Probiotic supplement, process for making, and packaging
US9232813B2 (en) 2008-07-07 2016-01-12 The Iams Company Probiotic supplement, process for making, and packaging
FR2938429B1 (fr) * 2008-11-19 2012-05-18 Oreal Utilisation cosmetique de microorganisme(s) pour le traitement des desordres du cuir chevelu
FR2945944B1 (fr) * 2009-06-02 2011-07-15 Oreal Procede cosmetique de traitement des etats pelliculaires comprenant l'administration d'un microorganisme probiotique et d'un actif antipelliculaire
FR2938437B1 (fr) 2008-11-19 2020-03-27 Société des Produits Nestlé S.A. Utilisation cosmetique de microorganisme pour le traitement des peaux grasses
WO2010013182A1 (en) * 2008-07-29 2010-02-04 L'oreal Cosmetic use of microorganism(s) for the treatment of scalp disorders
FR2937536B1 (fr) * 2008-10-28 2016-07-01 Oreal Utilisation cosmetique d'un lysat de bifidobacterium species pour le traitement du cuir chevelu gras
FR2937547B1 (fr) 2008-10-28 2012-11-09 Oreal Utilisation d'un lysat de microorganisme pour le traitement des peaux grasses
FR2940908B1 (fr) 2009-01-12 2012-08-24 Oreal Association cosmetique d'un microorganisme et d'un derive phytosphingosine
FR2942720B1 (fr) * 2009-03-03 2024-01-19 Oreal Utilisation cosmetique d'hesperidine.
FR2942719B1 (fr) * 2009-03-04 2011-08-19 Oreal Utilisation de microorganismes probiotiques pour limiter les irritations cutanees
EP2251022A1 (en) * 2009-05-11 2010-11-17 Nestec S.A. Non-replicating micro-organisms and their immune boosting effect
WO2010130663A1 (en) * 2009-05-11 2010-11-18 Nestec S.A. Bifidobacterium longum ncc2705 (cncm i-2618) and immune disorders
US8691303B2 (en) * 2009-07-31 2014-04-08 The Iams Company Dusted animal food
US9173423B2 (en) 2009-07-31 2015-11-03 The Iams Company Animal food kibble with electrostatically adhered dusting
US9210945B2 (en) * 2009-07-31 2015-12-15 The Iams Company Animal food having low water activity
US10104903B2 (en) 2009-07-31 2018-10-23 Mars, Incorporated Animal food and its appearance
US20110027417A1 (en) 2009-07-31 2011-02-03 Patrick Joseph Corrigan Process for Dusting Animal Food
FR2951377B1 (fr) * 2009-10-21 2012-06-22 Oreal Association d'un lysat de probiotique et d'un derive c-glycoside
FR2953408B1 (fr) * 2009-12-08 2013-02-08 Oreal Microorganismes probiotiques a titre d'actif pour l'eclat du teint de la peau
FR2953407B1 (fr) * 2009-12-08 2013-06-14 Oreal Microorganismes probiotiques a titre d'actif contre les alterations du microrelief
KR101807328B1 (ko) * 2010-01-06 2017-12-08 가부시키가이샤 야쿠르트 혼샤 경구용 ｄｎａ 손상 수복 촉진제 및 엘라스타아제 활성 억제제
FR2959128B1 (fr) 2010-04-23 2012-07-13 Oreal Utilisation cosmetique d'un lysat de bifidobacterium species pour le traitement des odeurs corporelles
EP2397145A1 (en) 2010-06-18 2011-12-21 Nestec S.A. L. johnsonii La1, B. longum NCC2705 and immune disorders
JP2010280664A (ja) * 2010-07-02 2010-12-16 Biogaia Ab ラクトバチルス・リューテリ（Ｌａｃｔｏｂａｃｉｌｌｕｓｒｅｕｔｅｒｉ）株を用いる哺乳類における免疫機能の改善方法
EP2449891A1 (en) * 2010-11-05 2012-05-09 Nestec S.A. Drinking yoghurt preparations containing non-replicating probiotic micro-organisms
US10039296B2 (en) 2011-06-20 2018-08-07 H.J. Heinz Company Brands Llc Probiotic compositions and methods
CN102335413B (zh) * 2011-08-16 2014-07-09 东北农业大学 一种具抗β-乳球蛋白过敏效果的乳杆菌完整肽聚糖的制备方法、产品及其应用
CN102578416B (zh) * 2012-02-23 2014-06-18 北京大北农科技集团股份有限公司 约氏乳杆菌在制备提高畜禽免疫水平饲料中的应用
KR20150065170A (ko) 2012-08-07 2015-06-12 탑제닉스, 인크. 관심있는 화합물을 발현하는 형질전환된 박테리아를 포함하는 국소 조성물
FR2999601B1 (fr) 2012-12-17 2015-01-30 Urgo Lab Methode pour prevenir et/ou traiter les infections, colonisations ou maladies liees a staphylococcus aureus, pseudomonas aeruginosa, streptococcus pyogenes, enterococcus faecium, enterobacter cloacae, proteus mirabilis et/ou bacteroides fragilis
FR2999931A1 (fr) 2012-12-21 2014-06-27 Oreal Utilisation de microorganismes probiotiques comme agent favorisant la synthese de melanine
FR2999932B1 (fr) 2012-12-21 2020-01-31 Société des Produits Nestlé S.A. Utilisation de microorganismes probiotiques comme agent favorisant la synthese de melanine
KR20170019427A (ko) 2014-06-17 2017-02-21 탑제닉스, 인크. Ｕｖ 차단을 위한 국소용 제형
DE202015004868U1 (de) 2014-07-11 2015-12-23 Mary Kay Inc. Topische Hautzusammensetzung und deren Verwendung
WO2016133909A1 (en) 2015-02-16 2016-08-25 Mars, Incorporated Interlocking kibble
AU2016255437B2 (en) 2015-04-28 2020-10-08 Mars, Incorporated Process of preparing a sterilized wet pet food product
LT6463B (lt) 2015-12-10 2017-10-10 Uab "Probiosanus" Probiotinių bakterijų (pb) gyvybingumo ir stabilumo padidinimas detergentų turinčiuose asmens higienos ir buities priežiūros produktuose
US20170173138A1 (en) * 2015-12-22 2017-06-22 Nestec Sa Immune health for companion animals
JP2019510037A (ja) 2016-03-31 2019-04-11 ゴジョ・インダストリーズ・インコーポレイテッド 抗菌ペプチド刺激性洗浄組成物
US10874700B2 (en) 2016-03-31 2020-12-29 Gojo Industries, Inc. Sanitizer composition with probiotic/prebiotic active ingredient
US10258567B1 (en) 2016-11-17 2019-04-16 Grace Procurements Llc Vaginal probiotic products and related processes
CN106727263B (zh) * 2016-11-22 2019-10-25 深圳弘睿康生物科技有限公司 皮肤微生态改善制剂及其制备方法
AU2017365019A1 (en) 2016-11-23 2019-07-11 Gojo Industries, Inc. Sanitizer composition with probiotic/prebiotic active ingredient
JP2020508357A (ja) * 2017-02-27 2020-03-19 コンティニュアム グループ エルエルシー 日焼け止め剤
JP7494110B2 (ja) * 2017-04-11 2024-06-03 セルバトゥス リミテッド 炎症及び炎症性疾患の治療法
JP7402689B2 (ja) * 2017-05-08 2023-12-21 ロレアル ケラチン基質細菌叢を改変するための化学または有機化合物でのコールド大気圧プラズマ処置
CA3084735A1 (en) * 2017-12-06 2019-06-13 Lac2biome S.r.l. Composition based on probiotics and uses thereof
CA3090042A1 (en) * 2018-02-02 2019-08-08 Postbiotica S.R.L. Use of a postbiotic-based composition for the treatment of skin diseases
KR102011240B1 (ko) * 2019-01-31 2019-08-14 에스케이바이오랜드 주식회사 신규한 락토바실러스 파라카제이 skb1192 균주 또는 이를 함유하는 광보호 효능이 있는 조성물 및 그 제품
CN110973254B (zh) * 2019-12-20 2023-03-14 光明乳业股份有限公司 一种可常温存放的活菌酸奶及其制备方法
KR102558085B1 (ko) * 2021-09-08 2023-07-24 코스맥스 주식회사 비피도박테리움 애니멀리스 서브스페시스 락티스 균주 및 그의 피부 상태 개선 용도

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1244691B (it) * 1991-01-29 1994-08-08 Sitia Yomo Spa Mousse lattea, suo impiego per preparare dessert e dessert cosi' ottenuti
JPH0517363A (ja) * 1991-07-11 1993-01-26 Yakult Honsha Co Ltd 抗炎症剤及びそれを含有する化粧料
KR950014592B1 (ko) * 1991-10-22 1995-12-11 주식회사태평양 화장료용 유산균제재
ES2124060T5 (es) * 1992-07-06 2002-12-16 Nestle Sa Bacteria lactica.
US5302389A (en) * 1992-08-17 1994-04-12 Board Of Regents, The University Of Texas System Method for treating UV-induced suppression of contact hypersensitivity by administration of T4 endonuclease
JPH0755908B2 (ja) * 1992-11-24 1995-06-14 財団法人京都パストゥール研究所 免疫機能助長剤
FR2705015B1 (fr) * 1993-05-10 1995-08-04 Agronomique Inst Nat Rech Produits du type fromages frais et leur procédé d'obtention.
JPH07194317A (ja) * 1993-12-29 1995-08-01 Nichinichi Seiyaku Kk ペットフード
FR2718752B1 (fr) * 1994-04-15 1996-07-12 World Trust Investment Sa Préparations à base de lactosérum fermenté et leurs utilisations.
FI104465B (fi) * 1995-06-14 2000-02-15 Valio Oy Proteiinihydrolysaatteja allergioiden hoitamiseksi tai estämiseksi, niiden valmistus ja käyttö
JPH092959A (ja) 1995-06-16 1997-01-07 Yakult Honsha Co Ltd ＩｇＥ抗体産生抑制剤および抗アレルギー剤
JP3995733B2 (ja) * 1995-07-17 2007-10-24 明治乳業株式会社 免疫賦活組成物
JPH09263539A (ja) * 1996-03-29 1997-10-07 Nichinichi Seiyaku Kk 抗真菌作用を有する皮膚疾患治療剤
JPH09301878A (ja) * 1996-05-13 1997-11-25 Youshindou:Kk 腫瘍増殖抑制剤
FR2750298B1 (fr) * 1996-07-01 1998-09-18 Gefa Composition en poudre pour la preparation d'un aliment a base de yaourt
JP2001506482A (ja) * 1996-09-10 2001-05-22 ソシエテ デ プロデユイ ネツスル ソシエテ アノニム 乳酸菌含有脱水食品
JP4064481B2 (ja) * 1996-10-11 2008-03-19 ハウスウェルネスフーズ株式会社 免疫賦活剤
JPH10139674A (ja) * 1996-11-11 1998-05-26 Yakult Honsha Co Ltd インターロイキン１２産生促進剤
EP0948262A1 (fr) * 1996-12-24 1999-10-13 Societe Des Produits Nestle S.A. Produit laitier fermente
ATE206873T1 (de) * 1997-01-09 2001-11-15 Nestle Sa Probiotik enthaltendes getreideprodukt
US6645506B1 (en) * 1997-04-18 2003-11-11 Ganeden Biotech, Inc. Topical compositions containing extracellular products of Pseudomonas lindbergii and Emu oil
WO1999017788A1 (en) * 1997-10-06 1999-04-15 Abbott Laboratories Composition of treatment of candidiasis
US5902743A (en) * 1998-03-20 1999-05-11 Wisconsin Alumni Research Foundation Probiotic bifidobacterium strain
JP2000095697A (ja) * 1998-09-18 2000-04-04 Advance Co Ltd 抗アレルギー剤
AU1543400A (en) 1998-12-11 2000-07-03 Urex Biotech Inc. Oral administration of lactobacillus for the treatment and prevention of urogenital infection
ID29150A (id) 1999-01-15 2001-08-02 Entpr Ireland Cs Penggunaan lactobacillus salivarius
DE19909820A1 (de) * 1999-02-22 2000-08-24 Heinz Nuenninghoff Kit zur Zubereitung eines Milch- oder Milchmischproduktes und Milch- oder Milchmischprodukt
FR2789854B1 (fr) * 1999-02-23 2001-05-25 Le Sojami Soc Procede de fabrication d'une preparation glacee a base de laits vegetaux, notamment de soja et produits obtenus
EP1034788A1 (en) * 1999-03-11 2000-09-13 Société des Produits Nestlé S.A. Lactic acid bacteria strains capable of preventing diarrhea
JP4388644B2 (ja) * 1999-10-18 2009-12-24 大洋香料株式会社 新規乳酸菌発酵代謝物を含有する化粧料
DE10021384A1 (de) * 2000-05-03 2001-11-15 Hora Reiner Ergänzungsfutter für Haustiere
JP2002037739A (ja) * 2000-07-24 2002-02-06 Mikimoto Pharmaceut Co Ltd 免疫調整剤

Also Published As

Publication number Publication date
AU2002220587B2 (en) 2006-06-29
US8377679B2 (en) 2013-02-19
JP2004510740A (ja) 2004-04-08
EP1593382A1 (en) 2005-11-09
BRPI0114400B8 (pt) 2021-05-25
CN100553646C (zh) 2009-10-28
JP4510376B2 (ja) 2010-07-21
EP1322318B1 (en) 2010-12-08
US20040013706A1 (en) 2004-01-22
ATE490776T1 (de) 2010-12-15
DE60143616D1 (de) 2011-01-20
EP1322318A1 (en) 2003-07-02
AU2058702A (en) 2002-04-15
WO2002028402A1 (en) 2002-04-11
US7547527B2 (en) 2009-06-16
BR0114400B1 (pt) 2014-04-01
US20100080782A1 (en) 2010-04-01
MXPA03002957A (es) 2005-06-30
CA2424607A1 (en) 2002-04-11
CA2424607C (en) 2013-01-15
PT1322318E (pt) 2011-03-15
ES2357419T3 (es) 2011-04-26
AR033580A1 (es) 2003-12-26
CN1468105A (zh) 2004-01-14

Similar Documents

Publication Publication Date Title
BR0114400A (pt) Uso de bactéria de ácido lático probiótica para equilibrar o sistema imunológico da pele
BR0206689A (pt) Combinação de probióticos, e, uso desta
AR029100A1 (es) Nuevos probioticos para aplicaciones de alimento de mascotas
EP2289939A3 (en) PAN-KIR2DL NK-receptor antibodies and their use in diagnostic and therapy
WO2006013441A3 (en) Use of probiotic bacteria for the preparation of topical compositions for skin protection
DE69929232D1 (de) Virusähnliche partikel zur induktion von autoantikörpern
UY26545A1 (es) " alimento para mascotas para tratar especies de helicobacter en mascotas."
BR0008912A (pt) Cepas de bactérias do ácido láctico capazes de prevenir a diarréia
BR0114105A (pt) Bactérias de acido lático capazes de reduzir uma tendência do indivìduo para desenvolver reações alérgicas
WO1998019167A3 (en) Cell stress regulated human mhc class i gene
TR200200301T2 (tr) Patojenik bakterilerin sebep olduğu ishali ölemeye elverişli bifidobakteriler
ITBS20120126A1 (it) Composizione antibatterica per uso topico
DE60236318D1 (de) Präparationen grampositiver bakterien zur behandlung von krankheiten mit immunfehlregulation
AR023141A1 (es) Medio sintetico para cultivar lactobacillus y bifidobacteria
Walter et al. Moderate effect of enamel matrix derivative (Emdogain® Gel) on Porphyromonas gingivalis growth in vitro
TR200001948T2 (tr) Mikobakteri vaccaesinden türetilen kompozisyonlar ve bunların kullanımları için metotlar.
ATE439851T1 (de) Verwendung probiotischer bakterien zur behandlung von infektionen
EP1889594A3 (en) Aqueous cataplasms containing watercress extract
BR0109928A (pt) Uso de um herpes vìrus atenuado, e, método para estimular uma resposta imune em um indivìduo humano ou animal, ou para tratar ou prevenir uma infecção patogênica ou câncer em um indivìduo humano ou animal
WO2001049319A8 (de) Zusammensetzung, enthaltend bakterielle antigene, zum vorbeugen und behandeln von allergischen erkrankungen
BR0012973B1 (pt) Uso de bactéria do ácido láctico pertencente ao gênero Bifidobacterium, e composição alimentícia ou farmacêutica.
DE59611307D1 (de) Nucleinsäure-moleküle codierend proteine, die die adhäsion von neisseria-zellen an humane zellen vermitteln
BR0007966A (pt) Composições e métodos para o tratamento e a prevenção de infecção bacteriana patogênica com base na função essencial da metilação do dna na virulência bacteriana
BR0009052A (pt) Utilização de uma fração de membrana debactérias gram negativas e composiçãofarmacêutica
ATE346602T1 (de) Bakterienwandfraktionen mit adjuvansaktivität

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 01/04/2014, OBSERVADAS AS CONDICOES LEGAIS.

B15K Others concerning applications: alteration of classification

Ipc: A61Q 17/04 (2006.01), A61K 8/99 (2017.01), A61K 35

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 04/10/2001 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 20A ANUIDADE.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2640 DE 10-08-2021 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.